Adolescent and young adult patients who were prescribed the oral antibiotic trimethoprim-sulfamethoxazole (TMP-SMX) in outpatient settings had a 30-day higher risk of acute respiratory failure than patients who started amoxicillin or…
TMP-SMX Linked to Higher 30-Day Respiratory Failure Risk in Adolescents and Young Adults
